LWLisheng Wang

Lisheng Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lisheng Wang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Bihong Liao

    Department of Gastroenterology, Second Clinical Medical College, Jinan University, Shenzhen People's Hospital, Shenzhen, Guangdong 510632, P.R. China

    1 shared publication
  • Guang Yang

    School of Life Science and Technology, ShanghaiTech University, 100 Haike Road, Pudong New Area, Shanghai 201210, China

    1 shared publication
  • Guanglei Li

    Department of Reproductive Medicine, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China

    1 shared publication
  • Jianqiao Liu

    Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital of Guangzhou Medical University , Guangzhou

    1 shared publication
  • Ru Zhang

    Department of Gastroenterology, Second Clinical Medical College, Jinan University, Shenzhen People's Hospital, Shenzhen, Guangdong 510632, P.R. China

    1 shared publication
  • Ruiyue Sh

    Department of Gastroenterology, Second Clinical Medical College, Jinan University, Shenzhen People's Hospital, Shenzhen, Guangdong 510632, P.R. China

    1 shared publication

Latest Publications

  • Open Access

    Efficient Generation of Pathogenic A-to-G Mutations in Human Tripronuclear Embryos via ABE-Mediated Base Editing

    by Guanglei Li, Xinyi Liu, Shisheng Huang, Yanting Zeng, Guang Yang, Zongyang Lu, Yu Zhang, Xu Ma, Lisheng Wang, Xingxu Huang, et al.


  • Pretreatment with bacterial components promotes DSS-injured colonic epithelial repair through the activation of STAT-3

    by Zhenglei Xu, Bihong Liao, Ru Zhang, Ruiyue Sh, Lisheng Wang

    Bacterial protection and epithelial repair are important against inflammatory bowel disease (IBD). The present study was designed to examine the effects of different bacterial components on the repair of normal and dextran sodium sulfate (DSS)‑treated colonic epithelial cells and the corresponding mechanisms. Human colonic epithelial cells (HT‑29) were pretreated with various doses of LPS or CpG‑dsDNA for 24 h and then treated with or without DSS for another 24 h. The epithelial repair was assessed by video analyses following mechanical injury. The epithelial expression of cluster of differentiation (CD)40 was assayed using flow cytometeric analysis. The production of interleukin (IL)‑6 and tumor necrosis factor (TNF) in the cell culture medium were measured using ELISA. The expression of p38 mitogen‑activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT)‑3 were examined using western blot analysis and reverse transcription‑quantitative polymerase chain reaction analysis. MAPK and STAT‑3 inhibitors were also administrated to observe signaling‑mediated repair. The results showed that pretreatment with lipopolysaccharide (LPS) or CpG‑dsDNA promoted epithelial repair of the DSS‑treated cells. The promoting effects were associated with the downregulation of CD40 molecules, inhibition of the p38 MAPK/TNFα pathway and activation of the STAT3/IL‑6 pathway. The STAT3 inhibitor abrogated the protective effects of LPS and CpG‑dsDNA on wound repair. These results demonstrated that LPS and CpG‑dsDNA induced preadaptation to DSS injury. This preadaptation was accompanied by the activation of STAT‑3. Thus, bacterial components may be used as a strategy for the therapeutic prevention of IBD. Related Articles